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A B S T R A C T
Age-related hearing (ARHL) loss affects a large part of the human population with a major impact on our aging
societies. Yet, underlying mechanisms are not understood, and no validated therapy or prevention exists. NADPH
oxidases (NOX), are important sources of reactive oxygen species (ROS) in the cochlea and might therefore be
involved in the pathogenesis of ARHL. Here we investigate ARHL in a mouse model. Wild type mice showed
early loss of hearing and cochlear integrity, while animals deficient in the NOX subunit p22phox remained un-
affected up to six months. Genes of the excitatory pathway were down-regulated in p22phox-deficient auditory
neurons. Our results demonstrate that NOX activity leads to upregulation of genes of the excitatory pathway, to
excitotoxic cochlear damage, and ultimately to ARHL. In the absence of functional NOXs, aging mice conserve
hearing and cochlear morphology. Our study offers new insights into pathomechanisms and future therapeutic
targets of ARHL.
1. Introduction
Presbycusis or age-related hearing loss is a frequent, degenerative
neurosensory disorder in ageing societies. Presbycusis affects more than
a third of the elderly population at retirement age [1]. Hearing loss in
this vulnerable population substantially contributes to cognitive de-
cline, depression and social isolation [2,3] and represents an important
socio-economic burden. Hearing aids and cochlear implants alleviate
symptoms, but are not a causal treatment. Finding new treatments to
reverse or slow down the progression of age-related hearing loss will
have major consequences for the affected individuals and for society as
a whole.
The etiology of presbycusis is multifactorial and involves a complex
interaction of genes. It can be triggered by a variety of external and
internal factors such as noise exposure, ototoxic molecules and medical
conditions, among others [4]. The histopathological correlates of age-
related hearing loss in the inner ear are the loss of mechanosensitive
hair cells, spiral ganglion neurons, supporting cells and cells in the stria
vascularis with a gradient from base to apex [5]. Therefore, the typical
age-related hearing loss is predominantly affecting the higher fre-
quencies, which are coded at the cochlear base.
Oxidative stress, i.e. high levels of reactive oxygen species (ROS),
has traditionally been thought to lead to tissue damage and eventually
cell death through non-specific protein, lipid and DNA oxidation.
However more recent concepts rather favor a role of physiological ROS
levels in cellular signaling [6], and a dysregulation of signaling through
excessive ROS levels [7]. Abundant evidence demonstrates changes in
the cochlear redox environment with age [8]. For instance, several
antioxidant genes, including SOD2, GST or UCP, have been associated
to age-related hearing loss [9] and genetic mouse models deficient for
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antioxidant genes, including Nrf2 [10,11], Sod1 [12] or genes reg-
ulating the mTOR pathway [13], show accelerated age-related hearing
loss. Furthermore, age-related hearing loss (ARHL) has been shown to
be slowed by supplementation with antioxidants in laboratory animals,
and a few studies have investigated the effect of antioxidants supple-
ments against ARHL in humans [14]. While a role of excessive oxidant
generation has been widely described as causative of hearing loss, the
exact sources of oxidants are unclear.
Fig. 1. Age-related hearing loss in wild type A/J mice: functional and morphological alterations in auditory neurons precede the loss of sensory epi-
thelium. A) Auditory brainstem response hearing thresholds of A/J mice were assessed from 4 to 26 weeks old animals, on a group of 11 WT A/J mice following
clicks and pure tone frequencies stimulation. B) Elevation of hearing threshold is accompanied with a decrease of the ABR maximal amplitude (peak to peak
amplitude, (p–p)), assessed at 75 dB SPL. C–F) Basal turn representative sensory epithelium immunostainings (Myo7a in green) of the WT A/J cochlea at 4 weeks old
(C), 6 weeks old (D), 18 weeks old (E) and 26 weeks old (F). G-J) On the same samples, the number of synaptic ribbons between inner hair cells (nucleus in white) and
spiral ganglion neurons was also determined using CtBP2 immunostaining (red dots), using 4 weeks old (G), 6 weeks old (H), 18 weeks old (I) and 26 weeks old (J)
mice. K–N) Representative mid-modiolar hematoxilin-eosin staining of A/J mouse basal cochlear turns at 4 weeks old (K), 6 weeks old (L), 18 weeks old (M) and 26
weeks old (N). O) Bar graph showing the quantification of outer hair cells (green), synaptic ribbons (red), SGN density (pink), ABR wave I amplitude (light grey) and
ABR threshold (black) in the 6 and 18 weeks old mice basal turn, relatively to the 4 weeks old group that serve as reference (100%). n = 11 animals. Scale bar
(C–F) = 25 μm, (G–J) = 10 μm and (K–N) = 50 μm. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of
this article.)
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NADPH oxidases (NOX) are a family of enzymes whose main bio-
chemical function is the production of ROS – namely superoxide radical
anion O2
•- and H2O2. In mammals, the NOX family consists of seven
isoforms (NOX1-5, DUOX1, 2). NOX have several subunits and the
p22phox subunit is crucial for the function of several NOX isoforms,
namely NOX1 to NOX4. In fact, p22phox is essential for NOX stabilisa-
tion and activity: the CYBA CRISPR knockout is devoid of ROS gen-
eration in NOX1, NOX2, NOX3 and NOX4 expressing cells [15].
Therefore, p22phox is a master regulator of ROS generation as it reg-
ulates most NOX-derived oxidants. The biological function of NOX-de-
rived ROS is broad, from host defense, to cellular signaling and hor-
mone biosynthesis. NOX-derived ROS and in particular H2O2, resulting
from superoxide dismutation are important second messengers in cell
signaling. Through a reversible reaction with H2O2, cysteine residues
are oxidized, changing the function of the respective protein [16].
Thereby, ROS regulates the activity of protein tyrosine phosphatases
[17], permeability of ion channels [18] or affinity of transcription
factors for their target DNA sequence [19] and thus regulate important
physiological function in the cell (i.e. proliferation, differentiation,
survival metabolism or motility). While NOX have important physio-
logical functions in virtually all organ systems, an over-activation of
these enzyme systems can lead to oxidative stress through over-
production of ROS and ultimately to oxidative stress-driven disease
(e.g. fibrosis, cardiovascular disease, neurodegeneration). We hy-
pothesize that in the inner ear, NOX activation results in hearing loss.
NOX3 is highly and exclusively expressed in the inner ear [20,21],
and its function has been mainly attributed to otoconia formation in the
developing vestibular system, whereas its function remains unknown in
the cochlear tissues [20,22]. Nox3 mutant mice develop a vestibular
deficiency, leading to a head-tilt phenotype. Mice with a loss of func-
tion mutation of the p22phox subunit show a similar vestibular pheno-
type as NOX3 mutant mice with, in addition, a defect of innate im-
munity due to the absence of NOX2 [23]. Although growing evidence
suggests a primary role of NOX and in particular NOX3 in different
cochlear pathologies [24]; the contribution of NOX isoforms in age-
related hearing loss has never been investigated. The fact that NOX3 is
exclusively expressed in the inner ear makes it a prime target for in-
terventions aiming at slowing down ROS production and consecutive
cell-damage in the inner ear. While NOX3 is only found in the inner ear,
more broadly expressed NOX family members are also present in the
inner ear and may contribute to hearing and balance disorders. Indeed,
NOX2 is highly expressed in microglia cells, which are abundant in
spiral ganglia [25], and inhibition of microglia activation was protec-
tive in a mouse model of neomycin-induced hearing loss [26]. NOX4 is
strongly expressed in vascular endothelium and could play a role in the
stria vascularis. And indeed, NOX4 overexpressing transgenic mice
show an increased sensitivity to noise-induced hearing loss [27].
Given the central role of p22phox in NOX activity, p22phox deficient
mice are a particularly useful tool for studying the role of NOX in inner
ear [23]. Indeed, considering the absence of Nox5 in the mouse, p22phox
deficient mice can be defined as pan-Nox-deficient mouse model [28].
The nmf333 mouse model (A.B6 Tyr + nmf333 – jax; A/J genetic
background) harbors a missense mutation in CYBA leading to a func-
tional inactivation of NOX1-4 [29]. The A/J strain shows a very early
age-related hearing loss and is therefore an interesting model to study
oxidative-related pathologies of the inner ear and to evaluate the effects
of potential otoprotective drugs [30].
In the present study, the A/J mouse model (nmf333) was used to
investigate the impact of NOX in the progression of age-related hearing
loss. Our data demonstrate that p22phox is a key regulator of age-de-
pendent hearing loss. Mechanistically, we show that p22phox regulates
the calcium release from intracellular stores in auditory neurons and
that deletion of p22phox protects from excitotoxic insult in auditory
neurons. Since, p22phox is a key regulator of redox pathways due to its
main function as controlling NOX activity, our data suggest a role of
oxidant-derived NOX in age-related auditory neuropathy and show
promises for novel therapeutic approaches for future treatment of age-
related hearing pathologies.
2. Results
A/J mouse as model for age-related hearing loss. In order to
characterize the early onset hearing loss in A/J mice, we investigated
hearing thresholds starting over an age range from 4 to 26 weeks
(Fig. 1A and B). Click-evoked auditory brain stem response (ABR)
hearing thresholds were close to 45 dB SPL in young adult mice (4
weeks old) and progressed up to 75 dB SPL in old mice (Fig. 1A). The
pure tone frequencies measurement (2–32 kHz) was more informative:
while young mice audiogram was comprised between 2 and 32 kHz
(with a threshold of 30 dB SPL at 11.3 kHz) (Fig. 1A; empty squares) we
observed a progressive loss of hearing at high frequencies narrowing
the hearing spectrum (from 32 kHz at 4 weeks to 5.7 kHz at 26 weeks
old). Accordingly, maximal amplitude of the ABR decreased with age
(Fig. 1B). The most important hearing loss was observed at around
11.3–16 kHz (Fig. 1A). Consistent with the high frequency hearing loss
phenotype, we observed a progressive degeneration of the sensory
epithelium from the base to the apical turn (Supplementary Fig. 1).
While the apical turn was relatively well conserved in old mice, there
was an important cellular degeneration in the basal region (Fig. 1C–F).
This was accompanied by a dramatic decrease in the number of sy-
naptic ribbons per inner hair cell (IHC) (Fig. 1G–J) and a marked de-
crease in the neuronal density in the spiral ganglion with age (Fig. 1K-
N). Interestingly, the kinetics of degeneration, as observed in the basal
turn of the cochlea, showed synaptic and post synaptic morphological
alteration (decrease in number of ribbons per IHC, auditory neuron
density and in the ABR wave I) occurring prior to the sensory epithe-
lium degeneration (Fig. 1O; the dotted line represent control values
obtained with mice at 4 weeks of age). Therefore, we conclude that A/J
mice have an early onset age-related hearing loss which is mainly
caused by neural degeneration and subsequent loss of the sensory epi-
thelium.
Pattern of NOX expression in the cochlea. While NOX3 is known
to be highly enriched in the inner ear, the presence of other NOX iso-
forms was not studied [24,31]. Therefore, we addressed the expression
of NOX isoforms in the cochlea of the human fetus (Fig. 2A) and the
adult A/J mouse (Fig. 2B–K). By qPCR, we found relatively high levels
of NOX2, NOX3 and NOX4 mRNA (CT values below 30) in both human
(Fig. 2A) and mouse cochlea (Fig. 2B). In both species, NOX1 and
DUOX1/2 levels in the cochlea were below detection threshold. NOX5
levels in the human cochlea were low (Ct values 33–35). Note that
NOX5 gene is absent in mice and rats [28]. The fetal cochlear tissues
used for real time qPCR is heterogenous and contained spiral ganglion
neurons, as well as parts of the stria vascularis. We therefore aimed to
obtain more precise information about the localization of the NOX
mRNA. There are major issues with antibodies for the different NOX
isoforms [32]. We therefore rather performed in situ hybridization
(using the RNAscope technology) in order to localize the mRNA of the
different isoforms (Fig. 2C–K). We compared expression of Nox2, Nox3
and Nox4 in three different subparts of the cochlea, namely the organ of
Corti, the stria vascularis and the spiral ganglia. Signals with the Nox2
and Nox4 probes (Supplementary Fig. 2) were detected throughout the
cochlea without a strong signal in specific parts. In contrast, the NOX3
probe gave a very strong signal in the spiral ganglia (Fig. 2H), com-
parable or even stronger than the control gene (Ppib, Fig. 2F;
Supplementary Fig. 3). The Nox3 signal also appeared above back-
ground in the stria vascularis (Fig. 2K), but not in hair cells (Fig. 2E).
p22phox deficient A/J mice are protected from early onset
hearing loss. As several NOX isoforms are present in the inner ear, we
next investigated hearing of A/J mice, harboring a loss of function
mutation on the NOX1-4 subunit p22phox (nmf333) (Fig. 3). For com-
parison, the results of wild type mice, as already described in Fig. 1, are
added. Hearing thresholds of mice were investigated monthly from 4 to
F. Rousset, et al. Redox Biology 30 (2020) 101434
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22 weeks old (Fig. 3A–F). Four weeks old p22phox mutant mice, ex-
hibited an audiogram profile similar to wild type littermates, indicating
that there is no basal difference in hearing between p22phox mutant and
WT mice (Fig. 3A). As already described in Fig. 1, from an age of 6
weeks, high frequencies hearing loss was observed in WT mice
(Fig. 3B–F, Fig. 3K). In contrast, only minor hearing impairment was
observed in mutant mice. In particular the high frequency hearing loss
was almost completely prevented in p22phox deficient animals up to 18
weeks old (Fig. 3K). In fact, the pattern of hearing loss was distinct in
p22phox deficient mice. At 22 weeks old, p22phox mutant showed only a
minor (statistically not significant) hearing loss. This minor hearing loss
appeared to be equally distributed along the tonotopic axis (Fig. 2F).
This is in contrast to the WT animal where the amplitude of the ABR
recorded at 75 dB SPL consistently showed age-dependent decrease at
high frequencies (Fig. 3H; Supplementary Fig. 4) and following click
stimuli (Fig. 3G). In addition to the hearing threshold elevation, WT
mice exhibited significant delay in the ABR wave I with age (Fig. 3I and
J). Together, these experiments clearly demonstrate the role of p22phox-
dependent NOX in age-related hearing loss in A/J mice.
Conserved architecture of the sensory epithelium in p22phox
deficient mice. Mice were sacrificed at different ages (6, 18 and 26
weeks old) for evaluation of cochlear histomorphology (Fig. 4, Fig. 5
and Supplementary Fig. 5). In young animals (6 weeks old), approxi-
mately at the onset of hearing loss, the sensory epithelium was overall
well conserved and comparable between WT and p22phox animals
(Fig. 4A–E). However, in contrast to p22phox deficient mice, we
Fig. 2. Pattern of NOX mRNA expression in the mouse and human cochlea. Expression level of Nox isoforms assessed by qPCR in human fetal cochlea (A) and 6
weeks old A/J mouse cochlea (B). Each graph shows the Ct values as observed for NOX1 to NOX5 and CYBA (p22phox). To note the absence of Nox5 in mice. Level of
expression of NOX1 and DUOX1/2 (not shown) was below the detection threshold. EEF1 was used as housekeeping gene. n = 3 to 6 cochlea/group. (C–K) mRNA
expression level of Nox3 in the organ of Corti (OC) (E), the spiral ganglia (SGN) (H) and the stria vascularis (SV) (K) of a 6 weeks old WT A/J mouse as assessed by in
situ hybridization (RNAscope®) (red dots). Peptidylprolyl isomerase B gene (Ppib) was used as positive control (C, F, I) and dihydrodipicolinate reductase (DapB)
expressed in the bacteria E. Coli was used as negative control (D, G, J). Nuclei were stained with DAPI (grey). Pictures are representative from 3 independent
experiments. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
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Fig. 3. p22phox-deficient mice are protected from early onset hearing loss. A-F) Audiogram of A/J WT (black triangles) versus p22phox deficient littermates
(white squares) as determined by auditory brainstem response following clicks and pure tone frequencies stimulation, from 4 to 22 weeks old mice. A) 4 weeks old, B)
6 weeks old, C) 10 weeks old, D) 14 weeks old, E) 18 weeks old and F) 22 weeks old. G-H) Bar graph showing ABR wave I amplitudes of WT and p22phox−/−
littermates at the indicated ages following G) click or H) 16 kHz pure tone stimuli at 75 dB SPL. I-J) Bar graph showing ABR wave I latencies of WT and p22phox−/−
littermates at the indicated ages following I) click or J) 16 kHz pure tone stimuli at 75 dB SPL. Note that at 16 kHz, the sound stimulus was below hearing thresholds
of 22 and 26 weeks old WT (Below threshold). K) Bar graph showing hearing threshold shifts at 18 weeks old. n = 11 WT; 12 p22phox+/-; 8 p22phox−/−.
F. Rousset, et al. Redox Biology 30 (2020) 101434
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observed a significant decrease in the presynaptic ribbons number
(Fig. 4F–J) and auditory neurons density (Fig. 4K-M) in the basal turn of
WT mice cochlea. On the functional level, this was accompanied by
significant decrease in the ABR wave I amplitude (Fig. 4N) which was
compensated by increased gain (wave IV amplitude) and modified ABR
wave IV/wave I ratio (Fig. 4O–P). Aged WT mice (18 weeks old;
Supplementary Figs. 5 and 26 weeks old; Fig. 5) exhibited significant
loss of OHC in the basal region of the cochlea, consistent with the high
Fig. 4. p22phox deficiency prevents age-related auditory neuropathy. A-D) Representative sensory epithelium immunostainings (Myo7a in green) of the basal
(A–B) and apical turn (C–D) of the A/J WT (A and C) and p22phox deficient (p22phox−/−) (B and D) cochleae, at the age of 6 weeks old. E) Bar graph showing the
number of outer hair cells (OHC)/section of 100 μm. F–I) On the same samples, the number of synaptic ribbons between inner hair cells and spiral ganglion neurons
was determined using CtBP2 immunostainings (red): F) and H) show respectively the WT mice basal and apical part of the cochlea. G) and I) show respectively the
p22phox deficient mice basal and apical turns of the cochlea. J) Bar graph showing the number of ribbons/inner hair cell (IHC). K-L) Representative mid-modiolar
hematoxylin and eosin staining showing the medial turn of 6 weeks old WT (K) and p22phox−/− littermate (L). M) Bar graph showing the density of spiral ganglion
neurons (SGN)/mm2 in the different parts of the cochlea of WT and p22phox−/− animals. n = 8 WT; n = 7 p22phox−/−. N–O) ABR wave I (N) and ABR wave IV
(O) amplitudes generated following clicks stimulation from 20 to 120 dB SPL (3 dB SPL increments) determined in 6 weeks old animals (WT in black; p22phox−/− in
grey). P) Graph showing the ratio value of waves IV/I amplitudes as recorded following click stimuli at increasing intensities. n = 11 WT; n = 8 p22phox−/−. (For
interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
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frequency hearing loss (Supplementary Figs. 5A–E and Fig. 5A–D).
Remarkably, architecture of the sensory epithelium of p22phox deficient
mice was fully preserved. In the apical turn, few missing OHC were
observed in both WT and p22phox deficient mice but without significant
differences. Accordingly in the basal turn of the cochlea, synaptic rib-
bons were virtually absent in wild type mice, while they were well
conserved in p22phox deficient mice (Supplementary Figs. 5F–J and
Fig. 5E–J). No significant differences were observed in the apex.
Overall, we observed that cochlear morphological and functional
changes observed in A/J mice appeared first at the synaptic/post-
synaptic level, anteceding the alteration of the sensory epithelium.
These damages were prevented by p22phox (Cyba) loss of function.
Gene expression profiling in the cochlea from wild type and
p22phox deficient mice. To further explore molecular pathways un-
derlying the protective effect of p22phox deletion in age-related hearing
loss, we performed cochlear transcriptome analysis of p22phox deficient
mice and WT littermates (Fig. 6). We chose young animals (6 weeks) to
identify early transcriptome alterations, anteceding the onset of hearing
loss. Our results revealed genes associated with several molecular
functions that were statistically significantly downregulated in p22phox
mutants (Fig. 6A). The most redundant molecular function which was
lower in CYBA mutant mice, is related to Ca2+ homeostasis, and in
particular ryanodine dependent Ca2+ release (FDR<0.05). Relevant
genes include all 3 isoforms of the ryanodine receptors (Ryr1, 2, 3),
involved in Ca2+ release from intracellular organelles, Otoferlin, Vamp1
and Snap25, involved in Ca2+ dependent pre-synaptic vesicle fusion
and Slc17a6, involved in glutamate transport (Fig. 6B). We also iden-
tified other genes involved in the auditory synapse function that
showed a trend towards lower expression albeit not significant in the
RNAseq analysis: the inner hair cells glutamate transporter (Slc17a8),
glutamate ionotropic receptor AMPA type subunit 2 (Gria2) and Ade-
nosine A1 receptor (Adora1) (data not shown). qPCR results confirmed
the significantly lower expression of ryanodine receptor 1, 2, 3, oto-
ferlin, Slc17a6, Slc17a8 and Gria2 (Fig. 6C). Except for genes associated
with ribbons (presynaptic: Vamp1, Snap25 and Otof), all genes were
significantly enriched in the SGN (postsynaptic Ryr1-3 Gria2, Adora1)
(Supplementary Fig. 6). Note that Ryr3 was poorly expressed in both
pre and post-synapse (Ct value of 32.6). Interestingly, downregulated
genes were all centered on Ca2+ and glutamate signaling and might
have a major role in the excitatory pathway of auditory neurons, a well-
known molecular pathway of hearing loss [8].
Analysis of the impact of adenosine and ryanodine on gluta-
mate-induced excitation of auditory neurons. To address the func-
tional relevance of these genes in the excitatory response, we measured
Ca2+ mobilization in the cytosol of auditory neurons in response to
glutamate (Fig. 6D and E). Auditory neurons were obtained from spiral
ganglia sphere forming stem cells as previously described [33]. While
the genesis of spiral ganglia from this system has been described pre-
viously, so far no studies addressing the glutamatergic function have
been performed on such a model. Upon glutamate stimulation, robust
and immediate increase in cytosolic Ca2+ concentration was observed
in the auditory neurons (Fig. 6D). This excitatory response was dose
dependent and showed an EC50 in the micromolar range (Fig. 6E), si-
milar to glutamate dose response curves reported in other systems
[34,35]. In cortical neurons, adenosine, through adenosine receptor
type I (Adora1), was shown to antagonize the glutamatergic pathway
[36]. Interestingly, Adora1 tended to be upregulated in mutant mice
cochlea (FDR = 0.1443). To investigate the functional relevance of
ryanodine receptors, we pre-incubated auditory neurons for 30 min
with ryanodine, which under these conditions inhibits glutamate-in-
duced Ca2+ release from the ryanodine-sensitive Ca2+ stores. We ob-
served a dose-dependent inhibition of Ca2+ release by ryanodine with a
maximal inhibition of 60%, suggesting that a substantial portion of
glutamate-induced Ca2+ elevations in auditory neurons originates from
ryanodine-sensitive Ca2+ stores (Fig. 6F, blue line and symbols). We
next investigated the functional impact of activation of adenosine re-
ceptors. We observed a dose-dependent inhibition of cytosolic Ca2+
elevation by adenosine with a maximal inhibition of 40%. Thus, similar
as seen in other types of neurons, adenosine receptors are inhibitors of
glutamatergic cell activation stores (Fig. 6F, magenta line and symbols).
Decreased Ca2+ induced Ca2+ release (CICR) in p22phox defi-
cient auditory neurons confers a protection against glutamate-
mediated excitotoxicity. To further characterize the excitatory func-
tion of p22phox−/− auditory neurons, we compared the expression of
key genes involved in glutamate response, namely ryanodine receptors
and glutamate ionotropic receptor Gria2 (Fig. 7A). The data
Fig. 5. p22phox deficiency prevents age-related histological alterations of the cochlea. A-D) Representative sensory epithelium immunostaining (Myo7a in
green) of (A–B) the basal and (C–D) the apical turn of the A/J WT (A and C) and p22phox deficient (p22phox−/-) (B and D) cochleae, at the age of 26 weeks old. E-H) On
the same samples, the number of synaptic ribbons between inner hair cells and spiral ganglion neurons was determined using CtBP2 immunostaining (red). E) and G)
respectively, represent the basal and apical part of the cochlea of WT mice. F) and H) are respectively, the basal and apical turns of p22phox deficient littermates. I-J)
Bar graph showing the number of ribbons/inner hair cell (IHC). n = 3 WT; n = 3 p22phox−/−. (For interpretation of the references to color in this figure legend,
the reader is referred to the Web version of this article.)
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demonstrate significant downregulation of ryanodine receptor 1 and 2,
as well as Gria2 in p22phox-deficient auditory neurons (Fig. 7A). To
understand the physiological relevance of this differential expression,
we compared glutamate-induced Ca2+ release in sphere-derived audi-
tory neurons from WT and p22phox−/− mice (Fig. 7B). Upon
glutamate stimulation, we observed a dose-dependent increase of Ca2+
cytosolic concentration with a comparable EC50 in both WT (5.635 μM)
and p22phox −/− (5.183 μM) auditory neurons. However, the overall
amplitude of the signal was significantly lower in p22phox −/− audi-
tory neurons (Fig. 7B; Supplementary Fig. 7). Furthermore, in absence
Fig. 6. NADPH oxidase-dependent upregulation of genes involved in the glutamatergic pathway. RNAseq analysis was performed on 6 weeks old WT and
p22phox deficient cochleae. n = 3 WT; n = 3 p22phox−/−. A) Bar graph shows gene ontologies in the molecular function category that were downregulated in
p22phox deficient mice. B) RNAseq data visualized on a volcano plot reveals several downregulated genes involved in synapse and post synapse function, particularly
in glutamate transport and signaling (green), Ca2+ dependent fusion of presynaptic vesicle (red) and Ca2+ induced Ca2+ release (blue). C) Bar graph showing
differentially expressed genes as assessed by qPCR and expressed relatively to WT cochleae. The Ct value for the WT cochlea is indicated in white. n = 5 WT; n = 5
p22phox−/− D) Ex vivo culture and stimulation of auditory neurons from WT A/J mice with increasing concentration of glutamate (0.1–50 μM). Before glutamate
treatment, auditory neurons were loaded with Ca2+ sensitive ratiometric probe (FLUO-8). Traces show the kinetics of cytosolic Ca2+ release upon glutamate
stimulation (black trace; glutamate 50 μM). E) Dose response curve of glutamate induced Ca2+ release allowing determination of glutamate EC50. F) Impact of pre-
treatment with ryanodine or adenosine (1–100 μM) on glutamate induced Ca2+ release. SGN were stimulated with 5 μM glutamate, corresponding to EC90. Data
represent the average± SEM of 3 independent experiments. (For interpretation of the references to color in this figure legend, the reader is referred to the Web
version of this article.)
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Fig. 7. p22phox deficiency mitigates glutamatergic response of auditory neurons and protects from glutamate-induced toxicity. A) mRNA levels of
Ryanodine receptor 1 (Ryr1), Ryanodine receptor 2 (Ryr2) and Glutamate ionotropic receptor AMPA type subunit 2 (Gria2) in spiral ganglion neurons from p22phox
deficient (grey bars) expressed relatively to WT mice (black bars, normalized to 1). n = 3 WT; n = 3 p22phox −/−. B) Dose response curve of glutamate induced
Ca2+ release in WT (black trace) and p22phox −/− (grey trace) auditory neurons. p < 0.0001 with two way ANOVA. C) Effect of increasing concentrations of
Ryanodine on glutamate-induced Ca2+ mobilization. Auditory neurons were pre-treated with ryanodine (0.3–100 μM) and stimulated with EC90 glutamate (5 μM).
The bar graph shows the relative effect of ryanodine on Ca2+ mobilization, induced by the glutamate treatment (WT, black; p22phox−/−, grey). D) The bar graph
shows the proportion of glutamate stimulated Ca2+ mobilization inhibited by the different concentrations of ryanodine. E) High glutamate concentration impact on
auditory neuron morphology. Auditory neurons from WT and p22phox-deficient A/J mice were cultured ex vivo and treated with glutamate 1 mM for 6 h. Cells were
then fixed with PFA 4% and subject to BIII tubulin immunostaining (red). Nuclei were colored with DAPI (blue). Pictures are representative of 3 independent
experiments. F) Bar graph showing the relative neurite length of auditory neurons treated or not with glutamate, normalized to the WT values. G) Impact of
increasing glutamate concentrations on auditory neuron viability. Auditory neurons from WT or p22phox-deficient A/J mice were cultured ex vivo and treated with
increasing concentrations of glutamate (0.1–3 mM). Viability was then assessed using an ATP measurement kit (ATP lite). Data represent the average± SEM of 3
independent experiments. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
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of p22phox, the ryanodine-sensitive Ca2+ release was significantly de-
creased (Fig. 7C and D), consistent with the lower expression of Ryr1
and 2 (Fig. 7A). Thus, we identified a functional role for p22phox in
auditory neurons, namely the control of Ca2+ release from ryanodine-
sensitive stores. Based on the results of the gene expression analysis, as
well as the functional characterization of the p22phox−/− and WT
spiral ganglia cells, we hypothesized that the lower amplitude of the
CICR in p22phox deficient auditory neurons is protective against gluta-
mate induced excitotoxicity. We therefore compared the impact of
glutamate on level of cellular integrity (ATP levels) and morphology of
WT and p22phox −/− spiral ganglia cells (Fig. 7E–G). Upon glutamate
exposure, WT auditory neurons showed dramatic morphological
changes, with, in particular loss of neurites (Fig. 7E). Following gluta-
mate exposure, neurite length in the WT cells was decreased by 50%
(Fig. 7F). Remarkably, p22phox deficient auditory neurons were almost
fully protected from glutamate induced morphological changes with
only minor decrease in average neurite length (not statistically sig-
nificant). The data also showed significant decrease in ATP con-
centration in WT SGN in a glutamate concentration dependent manner
(Fig. 7G). By contrast, the ATP content did not significantly decrease
after glutamate exposure in p22phox-deficient cells. Together, the data
demonstrate that downregulation of the excitatory pathway confers a
protection against glutamate mediated toxicity in p22phox deficient
auditory neurons.
3. Discussion
Our results provide the new evidence that the absence of functional
p22phox in the inner ear robustly protects from age-related hearing loss
and related morphological changes in mice. Mechanistically, we found
that the protection is mediated by decrease of the excitatory calcium/
glutamate signaling pathway in auditory neurons.
Our data provide an in-depth description of the early and pro-
gressive hearing loss in A/J mice over the first 6 months of life, beyond
and in line with earlier reports [37,38]. In this background, onset of
hearing loss occurs at 6 weeks of age together with predominant signs
of synaptic and post-synaptic damages, including loss of auditory
neurons and synaptic ribbons, as well as a decreased amplitude of ABR
wave 1. Consistent with recent report in human [39], the auditory
neuropathy precedes loss of hair cells, which occurs at a later stage in
our model. This model mimics the progression of human presbycusis as
the hearing loss in A/J mice starts in the high frequencies while lower
frequencies are only affected later in life. Three mutations known to
affect hearing are present in A/J mice, thereby providing structural and
metabolic explanations for the severe and rapid age-related hearing
loss. These include: i) a mutation in the age-related hearing loss-1 (ahl1)
locus, which codes for cadherin 23, a structural protein of the stereo-
cilia; ii) a mutation in ahl4, coding for citrate synthase, a mitochondrial
enzyme of the Krebs cycle, important for ATP and NADPH synthesis and
iii) mitochondrially encoded tRNA arginine, leading to a decreased
efficiency in amino acid incorporation. Interestingly, a recent in vitro
study demonstrated that decreased citrate synthase expression leads to
increased production of ROS [37]. This increase of ROS was proposed to
be due to a decrease in the cellular antioxidant system. However, the
fact that p22phox mutation can almost fully prevent the age-related
hearing loss in spite of the presence of the above-mentioned mutations
suggests that p22phox and/or its downstream pathways are major driver
of age-related hearing loss.
The A/J mouse model is a powerful tool for the study of age-related
hearing loss and otoprotection. As the absence of p22phox abolishes
NOX1–4 catalytic activity, our data strongly support a role of NOX-
derived ROS in presbycusis. However, the NOX isoform involved in
hearing loss remains to be identified. Nevertheless as of today, the
differential distribution of NOX isoforms in the inner ear has not been
clearly elucidated. Given the problems of specificity of commercially
available NOX antibodies [32], we focused our efforts on detection of
NOX mRNA by qPCR and in situ hybridization providing a striking si-
milarity of NOX isoform expression between human and mouse. The
qPCR experiments confirmed high expression levels of NOX3 and
p22phox, but also provided evidence of high levels of NOX2 and NOX4 in
the cochlea. The in-situ hybridization experiments using the high-re-
solution technology RNAscope® yielded relevant new information.
Nox2 and Nox4 mRNA appeared equally distributed throughout the
cochlea. We had rather expected some strong Nox2-positive microglia
cells in the region of the spiral ganglion. Note however that quiescent
microglia express only low levels of Nox2, which most likely explains
our observations. The most striking result was the high level of Nox3
mRNA in the spiral ganglion cells and its virtual absence in hair cells.
This finding supports a role of Nox3 in the morphological changes
observed in the cochleae of 6 weeks old animals, where at the first onset
of hearing loss, ribbons and SGN density are affected but not hair cells.
At this point, it is not clear whether the p22phox-dependent degenera-
tion of hair cells is secondary to degeneration of SGN or whether it is an
independent process that occurs later in time. Concerning the first op-
tion, it is unlikely that degeneration of SGN by itself leads to loss of
outer hair cells, as at least in the case of peripherin knock-out mice,
SGN, but not OHCs are lost [40]. However we cannot exclude some
NOX3-dependent efferent signaling mechanism that leads to a sec-
ondary OHC death. Yet, the second option, namely a delayed SGN-in-
dependent OHC death, certainly appears possible. While under phy-
siological conditions in 6 week old mice, expression levels of NOX3 was
low, it might be upregulated with aging. Indeed, there are indications
that upon stress, Nox3 might be upregulated in hair cells [31]. Alter-
natively other p22phox-dependent NOX enzymes might be upregulated
in the aging mice. Cell type-specific NOX knock-out will be necessary to
definitively clarify this issue.
The magnitude of the protective effect of p22phox deficiency is re-
markable. Indeed, up to 6 month of age, there was only a minor hearing
loss in p22phox mutant mice, while wild type A/J mice were virtually
deaf at this age. This raises the question how the lack of p22phox can
have such a profound effect. Indeed, NADPH oxidase are not the only
source of ROS in the cochlea (e.g. mitochondria are probably im-
portant), and mechanisms other than ROS are also likely to play a role
in cochlear damage [8]. Thus, p22phox may represent “the straw that
breaks the camel's back”, i.e. the cumulative effect of many insults leads
to hearing loss and by removing one of them (i.e. p22phox), the function
of the cochlea is maintained.
Our results demonstrate that p22phox loss of function is strikingly
important in sensory neurons as it leads to a lower expression of genes
of the neuronal excitatory pathway in the cochlea. This supports a key
role of NOX-derived ROS in this mechanism. Downregulated genes
harbor functions in Ca2+ signaling (ryanodine receptors 1,2,3), in sy-
naptic transmission (Otoferlin, Snap25 and Vamp1), as well as in the
glutamatergic pathway (Slc17a6, Slc17a8 and Gria2). The cytosolic free
Ca2+ concentration plays a key role in pre- and post-synaptic auditory
signal transmission. On the presynaptic side, Ca2+ influx through Ca2+
channels activates synaptic vesicle fusion and subsequent glutamate
release [41–43]. On the post-synaptic side, glutamatergic transmission
involve the glutamate ionotropic AMPA type subunit 2 (Gria2) leading
to Ca2+ increase in auditory neurons [44]. The lower expression of
neuronal excitatory genes may be explained by a delay in development
as previously described [45] or to a downregulation of these genes in
p22phox mutant mice. Interestingly, lower expression levels of ryano-
dine receptors in p22phox mutant mice are sufficient for normal hearing.
However, our data also suggest that enhanced expression of ryanodine
receptors leads to glutamate-induced toxicity and subsequent hearing
loss, which was mitigated in p22phox loss of function mice. In our in vitro
auditory neuron model, we provide direct evidence that ryanodine re-
ceptors are involved in the post-synaptic Ca2+ signal: glutamate-in-
duced Ca2+ elevations are inhibited by ryanodine in a dose-dependent
manner. From the relative inhibition of the Ca2+ signal, we can con-
clude that ryanodine receptors are important mediators of the
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excitatory signal in the cochlea at the post synaptic level. This ob-
servation is consistent with previous findings that AMPA-type gluta-
mate receptors and intracellular Ca2+ stores are coupled via RyR-de-
pendent CICR in primary auditory neurons [46]. Furthermore,
intracochlear perfusion of ryanodine in guinea pigs in vivo has been
shown to decrease auditory nerve compound action potentials, in-
dicating the importance of RyRs in cochlear transduction [47]. Direct
activation of Ryr2 by ROS is well-documented [48,49], however, in the
present study, transcriptomic data suggest that NOX-derived ROS rather
act at the transcriptional level. Further characterization of the pro-
moters and the transcriptional machinery will be required to under-
stand whether specific redox-sensitive transcription factors are in-
volved.
To explore key finding of our study, namely a protection of p22phox-
deficient animals from age-related hearing loss, other findings need to
be discussed. The A1AR adenosine receptor has been shown to be
linked to hearing loss and NOX signaling: mice deficient for the A1AR
exhibit greater susceptibility to noise exposure [50] and A1AR activa-
tion confers protection against cisplatin ototoxicity through down-
regulation of NOX3 [51]. Our results show only a trend towards in-
creased levels of A1AR in p22phox-deficient mice (p = 0.0064;
FDR = 0.1443). Interestingly, A1AR is an inhibitor of the excitatory
pathway [52,53], and in our hands, adenosine significantly decreased
the excitatory signal in auditory neurons (Fig. 6). This might provide an
additional element for the understanding why p22phox-deficient mice
are protected.
To the best of our knowledge, this is the first study investigating
age-related hearing loss in p22phox deficient mice. However, the impact
of Nox3 deletion has respectively been addressed in the context of
cisplatin [31] and noise [38] induced hearing loss. The first study re-
ports a protective impact in cisplatin-induced hearing loss following
injection of Nox3 siRNA in the middle ear while the second publication
by Lavinsky and collaborators using Nox3 mutant mouse concluded
that Nox3 might be protective against noise-induced inner ear damage.
In terms of pattern of hearing loss, the Lavinsky study did not show an
impact of Nox3 deficiency on noise-induced hearing loss at high fre-
quencies, but a small protective effect of Nox3 at low frequencies,
statistically significant only at 8 kHz. Our results studying age-related
hearing loss showed a protective effect of p22phox deficiency at fre-
quencies above 8 kHz. The reason for these apparently conflicting data
may be due to i) differences in the type of hearing loss (noise-induced,
ototoxicity and age-related), ii) mice in a different genetic background
were studied (black6 vs A/J), and iii) importantly, a different type of
NOX-deficient mouse was investigated (NOX3-deficiency vs. p22phox
deficiency, corresponding to a functional NOX1-4 knock-out). Future
studies addressing each isoform regulated by p22phox may provide a
better understanding of such differences.
Our study provides first conclusive evidence that p22phox is key
regulator of age-related hearing loss, most likely through regulation of
the activity of ROS-generating NADPH oxidases. The extent of the
protection of p22phox-deficient animals is astonishingly strong. Our data
suggest that p22phox – master regulator of the NOX pathway – is not
only regulating the levels of non-specific ROS-induced damage in the
cochlea. In fact, we demonstrate that level of expression of genes of the
excitatory pathway is strikingly diminished in p22phox mutant mice.
Thus, our data suggest that NOX-enhanced excitotoxicity contributes to
age-related hearing loss. We believe that targeting NOX catalytic ac-
tivity is a promising strategy to prevent age-related hearing loss. Small
molecules NOX inhibitors would be interesting tools, but might be
difficult to target to the inner ear. Local delivery of molecular therapies
(i.e. RNA knock-down of p22phox) may provide long term protection
against presbycusis and other related inner ear damage, but will equally
have to be precisely targeted [54].
4. Methods
4.1. Animal procedures
A.B6 Tyr+-Cybanmf333/J mice were purchased from Jackson lab
(strain 005445) and colonies were maintained at the animal facility of
the University of Geneva through heterozygous x heterozygous mating,
ensuring equal proportion of WT and p22phox deficient littermates. Both
male and female, were subjected to hearing threshold determination
using the auditory brainstem response at different time points from 4
weeks old to 26 weeks old. At the end of the experiments, animals were
sacrificed for cochlea histology or mRNA extraction. For the auditory
tests, or before sacrifice, mice were anesthetized with a mix of Ketamine
(100 mg/kg) and Xylazine (10 mg/kg).
4.2. Auditory brainstem response
Animals were anesthetized by intraperitoneal injection Ketamine
100 mg/kg and of Xylazine 5 mg/kg, and placed upon a heating pad to
maintain body temperature. Depth of anesthesia was tested every
30 min by testing the pedal withdrawal reflex. If necessary, additional
injections of about 50% of the initial dose were given. ABR recordings
were performed in a sound proof chamber (IAC Acoustics, Illinois IL,
USA). For stimulus generation and recording of responses, a multi-
function IO-Card (National Instruments, Austin TX, USA) was used,
housed in an IBM compatible computer. An integrated software
package for stimulus generation and recording (Audiology_lab;
Otoconsult, Frankfurt, Germany) was used. Sound pressure level was
controlled with an attenuator and amplifier (Otoconsult, Frankfurt,
Germany). Stimuli were delivered to the ear in a calibrated open system
by a loudspeaker (AS04004PR-R, PUI Audio, Inc., Dayton, USA) placed
3 cm lateral to the animals’ pinna. Sound pressure was calibrated on-
line prior to each measurement with a microphone probe system (Bruel
&Kjaer 4191) placed near the animals’ ear. Recorded signals were
amplified and bandpass filtered (80 dB; 0.2–3.0 kHz) using a filter/
amplifier unit (Otoconsult, Frankfurt, Germany). For the recordings,
silver electrodes were placed subcutaneously on the mouse forehead
(+), on the mastoid of the recorded ear (−) and a reference electrode
on the back. ABR were recorded, following stimulation with 100μs
clicks or 3 ms tone pipes (2.0–45.2 kHz at a resolution of 2 steps per
octave). For all frequencies, ABRs were recorded from 0 to 90 dB SPL in
3 dB steps. Electrical signals were averaged over 256 repetitions of
stimulus pairs with alternating phase. Hearing thresholds were defined
as the sound pressure level where a stimulus-correlated response was
clearly identified by visual inspection of the averaged signal.
4.3. Cochlea histology (mid modiolar cut, cytocochleograms and ribbons
staining)
At the end of the last ABR measurement, anaesthetized mice were
sacrificed by cervical dislocation followed by decapitation. Temporal
bones were isolated from the skull in order to extract the inner ears, and
after proper dissection cochlea were placed in 4% paraformaldehyde
overnight at room temperature. Cochleae were decalcified using USE-
DECALC solution (Medite commercial solution) under sonication for
48 h (following ultrasonic technique of USE 33 decalcification machine
from Medite, Cat. No. 03-3300-00). Finally, decalcified cochlea were
microdissected to perform cytocochleograms and im-
munohistochemistry, or mid modiolar cuts (embedded in paraffin) with
Hematoxilin-Eosin staining. As general rule, one ear from each animal
was used for cytocochleograms and the other ear for mid-modiolar
staining.
4.3.1. Immunohistochemistry and confocal microscopy (cytocochleograms)
Decalcified cochleae were microdissected with thin forceps under
binocular microscope. The bony shell was removed to expose the Organ
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of Corti (OC), followed by the removal of the stria vascularis and se-
paration of the sensory epithelium from the spiral ganglion. The basal
and middle turns of the OC were cut in two pieces each one and the
apical turn was preserved as one piece, resulting in 5 pieces transferred
into 400 μL PBS solution in a 48 well plate. Samples were then per-
meabilized (3% Triton-X 100 in PBS 1X) for 30 min at room tempera-
ture and immersed in a blocking buffer, containing 2% bovine serum
albumin (BSA) and 0.01% Triton-X 100 in PBS, for 1 h at room tem-
perature. Explants were incubated with anti-MyoVIIa (1:200, rabbit;
Proteus, USA) and anti-CtBP2 (1:200, monoclonal mouse, BD
Bioscience) antibodies in blocking buffer overnight at 4 °C. On the
following day, tissues were rinsed three times with PBS and incubated,
for 2 h at room temperature, with the secondary antibodies anti-rabbit
Alexa Fluor 488 (1:500; Invitrogen, USA) and goat anti-mouse Alexa
555 (1:500; Life Technologies) diluted in blocking buffer. Explants were
washed 3 times with PBS and mounted on a glass slide with
Fluoroshield containing DAPI (Sigmaaldrich, USA). The labelled cells
were visualized with a confocal laser-scanning microscope (Zeiss
LSM700) equipped with a CCD camera (Leica Microsystems) employing
the Plan-Neofluar 20X/0.50 and Plan-Apochromat 63X/1.4 (Oil) ob-
jectives. Hair cell and ribbons counting was performed using image J
software.
4.3.2. Mid modiolar hematoxylin eosin staining
Decalcified cochlea were dehydrated and embedded in paraffin.
Mid-modiolar cuts of 5 μm were processed and loaded onto gelatin-
coated slides. Harris’ Hemalun/eosin staining was performed on the
slides. The samples were qualitatively analyzed for density of spiral
ganglia using image J software.
4.4. Quantitative analysis of cochlea morphology
The SGN density was determined by nuclear counting, employing
the hematoxylin-eosin stained slides, of the Rosenthal's canal at each
different cochlear turn (apical, medial and basal). Five non-consecutive
sections were evaluated. To normalize the data, the total neuronal
amount was divided between each Rosenthal's area (in mm2), and the
measured densities were averaged. For the synaptic ribbons count, 10-
15 μm Z stack (0.7 μm steps) were performed with the 63X objective
and merged in a single picture, to ensure a proper counting of the
ribbons distributed along the Z axis. For each section of the OC, ribbons
belonging to two different segments of 10–15 inner hair cells were
counted to obtain an average of each cochlear turn. Additionally, 20X
pictures were employed to evaluate hair cells (HC) survival (cytoco-
chleogram). Inner hair cells (IHC) and outer hair cells (OHC) population
were recorded in two representative areas of 100 μm from each co-
chlear section, in order to average the HC survival rate of each turn
(apical, medial and basal). The open source image J program was used
for the image analysis.
4.5. Gene expression analysis
4.5.1. Mouse cochlea RNA extraction
Cochlea were quickly dissected in cold PBS, carefully removing re-
maining blood and surrounding tissues, immediately frozen in liquid
nitrogen and kept at −80 °C for further RNA extraction. Cochlea were
physically homogenized with clean steel balls and tissueLyser (Qiagen)
for 30 s at 30 rpm, and the DNA and RNA precipitated with 750 μl
Trizol. After adding 150 μl chloroform, (shaking, resting and centrifu-
ging step) we collected the aqueous phase and performed column
purification with Qiagen RNeasy Micro kit, ignoring the lysis and
homogenization steps described in the kit protocol (adding directly
70% ethanol) (adapted from Ref. [55]).
4.5.2. Human foetal cochlea RNA extraction
The inner ear was isolated from aborted human fetuses ranging from
W8 to W12 post conception. Procurement and procedures were per-
formed with full approval by the Ethics Committee of the State Geneva,
Switzerland and following signed informed consent of the donors. The
postmenstrual date was used for the calculation of the fetal stage. Tissue
dissection was performed in ice-cold Hanks’ balanced salt solution
(HBSS). The rest of the procedure was similar as for mouse cochlea RNA
extraction (see paragraph above).
4.5.3. Real time quantitative polymerase chain reaction
Following the cochlear extraction, RNA concentration was de-
termined using a Nanodrop. 500 ng of RNA was used for cDNA synth-
esis using the Takara PrimeScript RT reagent Kit, following manufac-
turer's instruction. Real-time PCR was performed using SYBR green
assay on a 7900HT SDS system from ABI. The efficiency of each primer
was verified with serial dilutions of cDNA. Relative expression levels
were calculated by normalization to the geometric mean of the three
house-keeping genes (Eef1a, Tubb and Actb for mouse and EEF1a, B2M
and GAPDH for human samples). The highest normalized relative
quantity was arbitrarily designated as a value of 1.0. Fold changes were
calculated from the quotient of means of these RNA normalized quan-
tities and reported as± SEM. Sequences of the primers used are pro-
vided in Supplementary Table 1.
4.5.4. RNAscope® (ACDbio, bio-techne, minneapolis, Minnesota, United
States)
Cochleae were fixed, decalcified and embedded in paraffin (see
above - mid modiolar cuts). 5 μm mid modiolar slices were loaded onto
gelatin-coated slides and subjected to RNAscope probe hybridization.
RNAscope Multiplex Fluorescent V2 assay (Bio-techne, Cat. No.
323110) or RNAscope 2.5 HD Assay – BROWN assay (Bio-techne, Cat.
No. 322310) was performed according to manufacturer's protocol,
paraffin sections were hybridized with the probes Mm-Nox3-C1 (Bio-
techne, Cat. No. 481989), Mm-Ppib-C1 (Bio-techne, Cat. No. 313911)
as positive control and DapB-C1 (Bio-techne, Cat. No. 310043) as ne-
gative control at 40 °C for 2 h and revealed with TSA Opal570
(PerkinElmer, Cat. No. FP1488001KT). For Fluorescent assay, tissues
were counterstained with DAPI and mounted with FluoromountG
(Bioconcept, Cat. No. 100.01). For BROWN assay, Tissues were coun-
terstained with Mayer hematoxyline for 30 s, dehydrated, cleared and
mounted with Tissue-Tek® Glas™ (Sakura, Cat. No. 1408). Samples were
visualized with a confocal laser-scanning microscope (Zeiss LSM700)
equipped with a CCD camera (Leica Microsystems) employing the Plan-
Neofluar 20X/0.50 and Plan-Apochromat 63X/1.4 (Oil) objectives.
Pictures were analyzed using image J software.
4.5.5. RNA seq
TruSeq ribodepleted stranded mRNA from 6 weeks old A/J mice (3
WT vs. 3 p22phox deficient) was applied to eliminate ribosomic RNA and
sequenced using Illumina TruSeq protocol. The sequencing quality
control was done with FastQC v.0.11.5. The sequences were mapped
with the TopHat v.2.0.11 software to the UCSC mm10 mouse reference.
The biological quality control and summarization were performed using
the PicardTools v.1.141. The table of counts with the number of reads
mapping each gene feature of UCSC mm10 was prepared with HTSeq
v0.6p1. The differential expression analysis was performed with the
statistical analysis R/Bioconductor package edgeR v. 3.14.0. Briefly, the
counts were normalized according to the library size and filtered. The
genes having a count above 1 count per million reads (cpm) in at least 4
samples were kept for the analysis. The initial number of genes in the
set was 23′420 and after the poorly or non-expressed genes were fil-
tered out, 15′126 genes were left. The p values of differentially ex-
pressed gene analysis were corrected for multiple testing problems
using the Benjamini-Hochberg (BH) procedure. All RNA-sequencing
data files were submitted to the arrayexpress database at EMBL-EBI
(www.ebi.ac.uk/arrayexpress) under the accession number E-MTAB-
8668.
F. Rousset, et al. Redox Biology 30 (2020) 101434
12
4.6. In vitro culture of mouse SGN
Mouse spiral ganglion neurons were isolated from p2-p5 A/J pups,
cultured and passaged as previously described [33]. Briefly, neuro-
spheres from spiral ganglia were maintained in DMEM:F12 with 1x N2
and B27 supplement in presence of bFGF, IGF1, Heparan sulfate and
EGF. For passages or differentiation, cells were dissociated with acutase
and mechanically disintegrated. Following filtration with a 70 μm filter,
retaining non dissociated spheres, SGN were counted and plated in a
384 or 96 well plate coated with matrigel (hESC qualified, Corning,
New York, USA) with medium without growth factors, in order to in-
duce differentiation. After 5 days of differentiation, cells were em-
ployed for cytosolic Ca2+ measurement and excitotoxicity assay.
4.7. Measurement of Ca2+ cytosolic release
16000 cells/well were differentiated to SGN on a 96 well plate
coated with matrigel, as described above (in vitro culture of spiral
ganglion neurons). Differentiated cells were loaded with FLUO-8
(Interchim, Montluçon, France) according to the manufacturer pro-
tocol. After 45min incubation at 37 °C, the glutamate-induced cytosolic
calcium release was assessed in a FDSS/μCELL Functional Drug
Screening System (Hamamatsu, Yokohama, Japan). The neuronal ki-
netics of calcium release was followed over 10min following glutamate
addition, with 1 measure every 0.5 s. The impact of ryanodine or
adenosine (0-100 μM), respectively added 30min or 24 h prior gluta-
mate, was also investigated.
4.8. Impact of high glutamate concentration on auditory neuron ATP
content
16000 cells/well were differentiated to SGN on a 96 well plate
coated with matrigel, as described above (in vitro culture of spiral
ganglions). Differentiated cells were then treated with increasing con-
centrations of glutamate for 6 h and the SGN viability was assessed
using the ATPLite kit (PerkinElmer, Wellesley, USA), following manu-
facturer's instructions using spectra L reader.
4.9. Impact of high glutamate concentration on auditory neuron
morphology
Auditory neuron progenitors were seeded on matrigel coated cov-
erslips and differentiated into auditory neurons for 5 days. Cells were
then exposed to 1 mM glutamate for 6 h and fixed for 10 min with PFA
4%. Following the fixation, neurons were permeabilized (0.2% Triton-
X100 in PBS 1X) for 30 min at room temperature and immersed in a
blocking buffer containing 2% BSA and 0.01% Triton-X 100 for 1 h at
room temperature. SGNs were incubated with the primary antibody
anti-BIII tubulin (1:1000, mouse; Biolegend, USA) in blocking buffer
overnight at 4 °C. On the following day, tissues were rinsed three times
with PBS and incubated with the secondary antibody anti-mouse Alexa
Fluor 555 (1:500; Invitrogen, USA) in blocking buffer for 2 h at room
temperature. Coverslips were washed 3 times with PBS and mounted on
a glass slide with Fluoroshield containing DAPI (Sigmaaldrich, USA).
The labelled cells were visualized with a confocal laser-scanning mi-
croscope (Zeiss LSM700) equipped with a CCD camera (Leica
Microsystems) with Plan-Neofluar 10X/0.30 NA objective. Neurite
length evaluation was performed using image J software.
4.10. Statistics
All data were analyzed using Two-way ANOVA followed by
Bonferroni multiple comparison test using GraphPad Prism software
unless where stated otherwise in the Figure legend. Values with
p < 0.05 was considered as statistically significant. *; p < 0.05,
**p < 0.01, ***; p < 0.005, ****p < 0.0005.
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